How to Fix the Top 5 Study Startup Bottlenecks

Top-performing sites activate studies in under 60 days while the median is 89 days. The difference? They’ve systematically eliminated five critical bottlenecks: feasibility delays, contract negotiations, IRB reviews, communication gaps, and task
handoffs. Here’s their playbook.

Clinical Trial Startup: From “Can We?” to “Let’s Go!”

Study Startup Steps

Study startup turns a protocol into a live, recruiting study. It includes feasibility, site selection, contract & budget negotiation, IRB/EC approvals, and site initiation visits—ending at site activation. Teams using modern, parallelized workflows (AI site selection, virtual SIVs, e-regulatory) compress timelines from 6–8 months to roughly 8–12 weeks.

Inside the Study Start-up Timeline: A View Most Research Teams Never See

If you’ve ever wondered why that promising clinical trial took six months to activate when everyone thought it would take six weeks, you’re not alone. The study start-up phase is clinical research’s best-kept secret—a complex orchestration of activities that happens largely behind the scenes, invisible to most research teams until delays start mounting. Most research […]

Scale Your Feasibility Response—Without Scaling Your Team

The Hidden Cost of Feasibility Overload If you’ve ever juggled six feasibility requests at once, you’re not alone—and you’re probably exhausted. For many clinical research teams, feasibility is deceptively labeled as “simple” paperwork. But behind each sponsor packet lies a web of deadlines, document versions, internal coordination, and unspoken stress. When multiple sponsors hit your […]